Diabetes mellitus is the leading cause of cardiovascular morbidity and mortality. Phlorizin (PHLOR) and quercetin-3-O-glucoside (QUER-3-G) are two natural compounds reported to have antidiabetic properties by inhibiting sodium/glucose transporters. 
Introduction
Diabetes mellitus (DM) is a major global health problem and thirty-five million people with DM live in the Middle East and North Africa. A variety of complications can arise from uncontrolled DM including cardiovascular diseases, neuropathy, nephropathy and retinopathy which makes it the leading cause of cardiovascular morbidity and mortality, blindness, endstage renal failure and non-traumatic limb amputations (International Diabetes Federation 2013) . Control of DM involves different approaches including lifestyle that involves increasing physical activity and weight loss, and therapeutic approaches that involve administration of medications (Ismail-Beigi 2012) . The development of new antidiabetic medications without the side effects associated with the use of other available drugs such as weight gain and hypoglycemia as with insulin, sulphonylureas and thiazolidinediones, and diarrhea and nausea as with metformin and incretin mimetics, is a continuous challenge (Chao and Henry 2010) . Sodiumglucose co-transporter (SGLT) inhibitors are a new class of antidiabetic drugs that work by a novel insulinindependent mechanism. SGLT inhibitors are subdivided into three subclasses including non-selective or dual SGLT1 and SGLT2 inhibitors such as phlorizin Vol. 65 (PHLOR) (Chao and Henry 2010) and LX4211 (Zambrowicz et al. 2012) , selective SGLT1 inhibitors such as quercetin-3-O-glucoside (QUER-3-G) (Cermak et al. 2004 , Gee et al. 1998 , KGA-2727 (Shibazaki et al. 2012 and KGA-3235 (Kissei Pharmaceuticals 2009) , and selective SGLT2 inhibitors such as dapagliflozin (Komoroski et al. 2009 ), canagliflozin (Sha et al. 2011 , seragliflozin (Katsuno et al. 2007 ) and ipragliflozin (Imamura et al. 2012) . PHLOR is a natural organic phenolic glycoside belonging to the chalcone class (Ehrenkranz et al. 2005 , Tahrani et al. 2013 . It was first isolated by French scientists in 1835 from apple tree bark. In 1886, von Mering observed that PHLOR produces glycosuria in doses above 1.0 g (Ehrenkranz et al. 2005) . PHLOR is the parent compound from which synthesized SGLT inhibitors were derived (Tsujihara et al. 1996) . PHLOR was not itself pharmaceutically developed as an SGLT inhibitor because it is poorly absorbed by the intestine. It is hydrolyzed to another compound phloretin which is an inhibitor of facilitative glucose transporter 1 (GLUT1) and thus has low oral bioavailability (Chao and Henry 2010). QUER-3-G is a flavonol glycoside that is found in several plants including apple, tea, onion, crataegus, pistachio nut, saint John's wort in addition to many fruits, vegetables and cereals (Razavi et al. 2009 , Valentová et al. 2014 , Wang et al. 2013 . In addition to inhibiting SGLT1, QUER-3-G has been reported to also inhibit alpha-glucosidase enzyme ). Therefore, it has dual antidiabetic action which may make it a good parent for the development of antidiabetic drugs. Our previous study showed that the selective SGLT2 inhibitor dapagliflozin significantly reduced the amplitude of shortening and Ca 2+ transient in myocytes from STZ rats (Hamouda et al. 2014) . Therefore, we extended this study to investigate also the effects of other SGLT inhibitors, like PHLOR and QUER-3-G, on shortening and intracellular Ca 2+ in ventricular myocytes from STZ-induced diabetic rats.
Materials and Methods

Ethical approval
This study was approved by the Animal Ethics Committee, College of Medicine & Health Sciences, United Arab Emirates University.
Experimental protocol
Experiments were performed in STZ-induced diabetic (n=14) and in age-matched Control rats (n=16).
Diabetes was induced in 2-month-old rats by injecting STZ (60 mg/kg, i.p.) dissolved in citrate buffer. Control rats received citrate buffer alone. Animals received standard rat chow and water ad libitum. Before each experiment, bodyweight, heart weight and non-fasting blood glucose were measured.
Ventricular myocyte isolation
Ventricular myocytes were isolated according to previously described techniques (Howarth et al. 2002) . In brief, rats were euthanized by use of a guillotine. Hearts were then quickly removed and mounted on a Langendorff system for retrograde perfusion. Hearts were perfused at a constant flow rate of 8 ml.g heart 3) until heart contraction had stabilized. Perfusion was then switched for 4 min to Ca
2+
-free cell isolation solution containing 0.1 mM/l EGTA and then for 6 min to cell isolation solution containing 0.05 mM/l Ca 2+ , 0.60 mg/ml type 1 collagenase (Worthington Biochemical Corp, Lakewood, NJ, USA) and 0.075 mg/ml type XIV protease (Sigma, Taufkirchen, Germany). Ventricle tissue was excised from the heart, minced carefully by the use of scissors and then gently agitated in collagenase-containing isolation solution supplemented with 1 % BSA. Cells were filtered from this solution at 4 min intervals and resuspended in cell isolation solution containing 0.75 mM/l Ca 2+ .
Measurement of ventricular myocyte shortening
Myocytes were allowed to settle on the glass bottom of a Perspex chamber mounted on the stage of an inverted microscope (Axiovert 35, Zeiss, Göttingen, Germany). Myocytes were superfused (3-5 ml/min) with normal Tyrode (NT) containing the following in mM/l: 140.0 NaCl, 5.0 KCl, 1.0 MgCl 2 , 10.0 glucose, 5.0 HEPES, 1.8 CaCl 2 (pH 7.4). PHLOR (Sigma-Aldrich, Saint Louis, Missouri, USA) and QUER-3-G (Sigma, Taufkirchen, Germany) were dissolved in dimethylsulphoxide (DMSO) to give a final concentration of 10 −6 M. This concentration was chosen based on a concentration-response experiment done in our previous study on dapagliflozin and to enable comparison with this study (Hamouda et al. 2014 
Measurement of intracellular Ca 2+ concentration
Myocytes were loaded with the fluorescent indicator Fura-2 AM (F-1221, Molecular Probes, Eugene, OR, USA) as previously described (Howarth et al. 2002) . A final Fura-2 concentration of 2.5 µM/l was obtained by adding 6.25 µl of a 1.0 mM/l stock solution of Fura-2 AM (dissolved in DMSO) to 2.5 ml of myocytes suspended in NT solution. Myocytes were loaded with Fura-2 AM by gentle shaking for 10 min at room temperature (24 °C). Myocytes were then centrifuged, washed with NT to remove extracellular Fura-2 and left for 30 min to ensure complete hydrolysis of the intracellular ester. Intracellular Ca 
Assessment of myofilament sensitivity to Ca
2+
Shortening and Fura-2 ratio were recorded simultaneously in some myocytes (Howarth et al. 2011) . Myofilament sensitivity to Ca 2+ was assessed from phaseplane diagrams of Fura-2 ratio versus cell length by measuring the gradient of the Fura-2-cell length trajectory during late relaxation of the twitch contraction. The position of the trajectory reflects the relative myofilament response to Ca 2+ and hence, can be used as a measure of myofilament sensitivity to Ca 2+ Qureshi 2008, Spurgeon et al. 1992) .
Measurement of sarcoplasmic reticulum Ca 2+ release
Sarcoplasmic reticulum (SR) Ca 2+ release was assessed according to previously described techniques (Bassani et al. 1995 , Howarth et al. 2002 , 1999 
Statistical analysis
Results are expressed as the mean ± SEM of 'n' observations. 'n' refers to number of rats or ventricular myocytes. Data were analyzed by either the Independent samples t-test or one-way ANOVA with Bonferroni post hoc for multiple comparisons as appropriate using IBM SPSS Statistics for Windows, Version 20.0. (IBM Corp., NY, USA). Statistical significance was set at P<0.05 and was denoted by horizontal lines on all graphs.
Results
General characteristics of streptozotocin-induced diabetic rats
Experiments began 2 months after STZ treatment. At the time of experiments, non-fasting glucose level was measured in blood taken from the tail vein to confirm diabetes. STZ rats had elevated nonfasting blood glucose level (469.64±22.23 mg/dl, n=14) compared to Controls (104.06±3.36 mg/dl, n=16). STZ rats had significantly (P<0.05) lower body weights (267.57±7.45 g, n=14) compared to Controls (352.25±9.09 g, n=16) , as well as significantly (P<0.05) lower heart weights (1.06±0.02 g, n=14) compared to Controls (1.2±0.03 g, n=16). Heart weight to body weight Vol. 65 ratio of STZ rats was significantly (P<0.05) higher (4.00±0.11 mg/g, n=14) compared to Controls (3.42± 0.05 mg/g, n=16).
Effects of phlorizin and quercetin-3-O-glucoside on ventricular myocyte shortening
Ventricular myocyte shortening was assessed in electrically stimulated (1 Hz) STZ and Control myocytes maintained at 35-36 °C. Figure 1 shows typical records of shortening in a Control myocyte during superfusion with NT, 5 min NT + PHLOR (Fig. 1A) or NT + QUER-3-G (Fig. 1B) and after 5 min washout with NT. The effects of PHLOR and QUER-3-G on RCL, TPK shortening, THALF relaxation and amplitude of shortening are shown in Figures 1C-J (Fig. 1D) ; however, TPK was significantly (P<0.05) shortened in STZ/QUER-3-G and in Control/QUER-3-G compared to STZ and Control myocytes (Fig. 1H) . THALF relaxation of shortening was not altered in STZ compared to Control or by PHLOR and QUER-3-G ( Figs 1E and I (Fig. 1F) . Amplitude of shortening was also significantly (P<0.05) reduced in STZ/QUER-3-G (79.12±2.28 %, n=20) and Control/QUER-3-G (76.69±1.92 %, n=30) myocytes compared to STZ and Control myocytes (Fig. 1J) .
Effects of phlorizin and quercetin-3-O-glucoside on ventricular myocytes intracellular Ca
2+
Intracellular Ca 2+ was measured in Fura-2 loaded, electrically stimulated (1 Hz) myocytes at 35-36 °C. Figure 2 shows typical records of Ca 2+ transient in a Control myocyte during superfusion with NT and NT + PHLOR ( Fig. 2A) or NT + QUER-3-G (Fig. 2B) (Fig. 2E) ; however, it was significantly (P<0.05) shortened by QUER-3-G in STZ/QUER-3-G and Control/QUER-3-G myocytes compared to STZ myocytes and Controls (Fig. 2I) (Fig. 2J) . Figure 3A and a phase plane diagram showing the relationship between the Fura-2 ratio and shortening is shown in Figure 3B . The gradient of the Fura-2-cell length trajectory was used to assess the relative myofilament response and sensitivity to Ca
Effects of phlorizin and quercetin-3-O-glucoside on ventricular myocyte myofilament sensitivity to
2+
. There was no significant difference in myofilament sensitivity to Ca 2+ in myocytes from STZ compared to Control myocytes (Figs 3C and D) or in STZ/PHLOR and Control/PHLOR compared to STZ and Control myocytes (Fig. 3C ). There was a modest reduction in myofilament sensitivity to Ca 2+ in STZ/QUER-3-G and a significant (P<0.05) reduction in myofilament sensitivity in Control/QUER-3-G compared to STZ and Control myocytes (Fig. 3D) . Vol. 65 Data are mean + S.E.M., n=10-12 myocytes from 3-4 rats for PHLOR and n=12-29 myocytes from 3-6 rats for QUER-3-G. 
Effects of phlorizin and quercetin-3-O-glucoside on ventricular myocytes sarcoplasmic reticulum Ca
Discussion
Similar to findings in previous studies, STZinduced DM was characterized by a 4-fold increase in blood glucose, lower body and heart weights and higher heart weight to bodyweight ratio compared to Control rats , Howarth and Qureshi 2001 , Howarth et al. 2002 . In the heart, the time course of myocyte shortening was prolonged in STZ compared to Control rats (Kotsanas et al. 2000 . This study investigated the effects of PHLOR and QUER-3-G on contractility and Ca (Cai et al. 2013) . PHLOR has also been shown to exert partial cardioprotection against isoproterenol-induced myocardial necrosis (Gupta et al. 2013) and to prevent electrically-induced ventricular tachyarrhythmia in guinea pig hearts during ischemia (Hirose et al. 2014 STZ-induced diabetic rats develop cardiovascular complications in a short period of time starting with reduced heart rate 5-7 days after injection, reduced mean arterial pressure 14 days after injection, and decreased heart rate and mean arterial pressure variability 30-45 days after injection (Schaan et al. 2004) . Although, experiments were carried out after 2 months of STZ injection allowing all the mentioned complications to develop, the extent of the observed effects of PHLOR and QUER-3-G on myocyte shortening and intracellular Ca 2+ current over a range of test potentials in rat STZ and Control myocytes (Hamouda et al. 2015) . Further experiments would be required to establish whether alterations in L-type Ca 2+ current are also involved in the negative inotropic effects of PHLOR and QUER-3-G.
Overall, PHLOR and QUER-3-G both reduced the amplitude of shortening to similar extents in STZ and Control myocytes. Owing to their negative inotropic effects, it is suggested that PHLOR and QUER-3-G might have a wide range of clinical applications in cardiovascular diseases such as angina, arrhythmias and hypertension. Considering their antidiabetic effects, they would be of a great benefit to diabetic patients who are prone to develop angina, myocardial infarction and congestive heart failure (International Diabetes Federation 2013).
